Fredun Pharmaceuticals Limited announced a private placement of 62,996 common shares at a price of INR 996.20 per share for proceeds of INR 62,756,615.2 to certain non-promoter entities; 37,140, each warrant convertible into 1 equity share of face value of INR 10; and 2,22,752 warrants at a price of INR 996.20 per warrant for proceeds of INR 221,905,542.4, each warrant, convertible into 1 Equity Share of face value of INR 10 each to certain non-promoters, on a preferential basis for total proceeds of INR 284,662,157.6 on August 27, 2022. The transaction has been approved by the board of directors of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
870.4 INR | -1.02% | +4.13% | +0.18% |
10/05 | Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24 | CI |
08/05 | Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9% | MT |
1st Jan change | Capi. | |
---|---|---|
+0.18% | 4.95Cr | |
+32.09% | 69TCr | |
+29.39% | 59TCr | |
-1.34% | 37TCr | |
+20.34% | 33TCr | |
+7.39% | 29TCr | |
+14.25% | 24TCr | |
-3.03% | 21TCr | |
+10.02% | 21TCr | |
+8.49% | 17TCr |
- Stock Market
- Equities
- FREDUN6 Stock
- News Fredun Pharmaceuticals Limited
- Fredun Pharmaceuticals Limited announced that it expects to receive INR 284.662157 million in funding